United Arab Emirates Consensus Recommendations for Management of Acne Vulgaris

J Drugs Dermatol. 2024 Aug 1;23(8):653-660. doi: 10.36849/JDD.7748.

Abstract

Acne in the United Arab Emirates is a common disease that causes burden to patients, has psychosocial impacts, and is associated with physical sequelae such as dyspigmentation and scarring. This guideline, which was developed from an evaluation of existing international and national evidence-based acne guidelines along with live meetings of United Arab Emirates acne experts, is designed to facilitate the management of acne in the UAE health care system. It discusses the evaluation of acne severity, evidence-based guidance on acne treatment, and strategies for the management of this chronic disease. Effective treatment of active lesions and prevention of sequela is likely to improve the health of many United Arab Emirates patients with acne. J Drugs Dermatol. 2024;23(8):653-660.  doi:10.36849/JDD.7748R1.

Publication types

  • Practice Guideline

MeSH terms

  • Acne Vulgaris* / diagnosis
  • Acne Vulgaris* / therapy
  • Consensus*
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / therapeutic use
  • Evidence-Based Medicine / standards
  • Humans
  • Practice Guidelines as Topic
  • Severity of Illness Index
  • United Arab Emirates / epidemiology

Substances

  • Dermatologic Agents